Simulations Plus, Inc. (NASDAQ:SLP – Get Free Report) Director Walter Woltosz sold 4,177 shares of Simulations Plus stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $18.44, for a total transaction of $77,023.88. Following the transaction, the director directly owned 3,202,131 shares in the company, valued at approximately $59,047,295.64. This trade represents a 0.13% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Simulations Plus Stock Performance
Shares of NASDAQ:SLP traded down $0.03 during midday trading on Monday, hitting $18.36. 340,704 shares of the company’s stock traded hands, compared to its average volume of 389,171. Simulations Plus, Inc. has a twelve month low of $11.09 and a twelve month high of $21.01. The company has a market cap of $370.87 million, a PE ratio of -5.87 and a beta of 1.30. The firm’s fifty day moving average price is $16.17 and its two-hundred day moving average price is $15.49.
Simulations Plus (NASDAQ:SLP – Get Free Report) last issued its quarterly earnings data on Thursday, April 9th. The technology company reported $0.35 EPS for the quarter, topping analysts’ consensus estimates of $0.27 by $0.08. Simulations Plus had a positive return on equity of 16.21% and a negative net margin of 77.96%.The company had revenue of $24.29 million for the quarter, compared to analysts’ expectations of $21.66 million. As a group, equities research analysts anticipate that Simulations Plus, Inc. will post 0.8 EPS for the current fiscal year.
Institutional Trading of Simulations Plus
Wall Street Analysts Forecast Growth
Several research firms have issued reports on SLP. Craig Hallum downgraded Simulations Plus from a “buy” rating to a “hold” rating and set a $18.50 price objective on the stock. in a report on Thursday, June 18th. TD Cowen cut their price target on shares of Simulations Plus from $19.00 to $16.00 and set a “hold” rating on the stock in a report on Friday, April 10th. William Blair downgraded shares of Simulations Plus from an “outperform” rating to a “market perform” rating in a research note on Wednesday, June 17th. Weiss Ratings raised shares of Simulations Plus from a “sell (d-)” rating to a “sell (d)” rating in a report on Friday, June 5th. Finally, Wall Street Zen downgraded shares of Simulations Plus from a “buy” rating to a “hold” rating in a research report on Saturday, June 13th. One equities research analyst has rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $20.90.
Read Our Latest Stock Report on Simulations Plus
Simulations Plus Company Profile
Simulations Plus, Inc (NASDAQ: SLP) specializes in advanced modeling and simulation software tailored to the pharmaceutical, biotechnology and chemical industries. The company’s flagship products include ADMET Predictor, a quantitative structure-activity relationship (QSAR) tool for predicting absorption, distribution, metabolism, excretion and toxicity properties, and GastroPlus, a physiologically based pharmacokinetic (PBPK) modeling platform for simulating drug absorption and pharmacokinetics.
Featured Stories
- Five stocks we like better than Simulations Plus
- Flash Crash or Cash? The AI Hardware Reset Investors Can’t Ignore
- As Employers Drop Obesity Drug Coverage, Hims & Hers Could Be the Winner
- KBR Insiders Are Buying While the Market Misreads Its Spinoff
- Contrarian Alert: 5 Downgraded Stocks That May Reward Long-Term Investors
Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.
